| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 2.47 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Drug development represents a highly complex, inefficient and costly process. Over the last decade, the
widespread use of nuclear imaging, due to its functional and molecular nature, has proven to be
determinant in improving the efficiency on selecting the candidate drugs that should be abandoned or
move forward to clinical. This reflects not only into the development of safer and effective drugs, but
also the shortening of time-to-market.
The modern concept and future trends concerning molecular imaging is assumedly hybrid or
multimodality imaging, including combinations between high sensitivity and functional (molecular)
modalities with high spatial resolution and morphological techniques
Description
Documento Técnico submetido para suporte à Candidatura ao Título de Especialista no Grupo 7 –
Saúde e Protecção Social / Área de Estudo 72 – Saúde / Área de Educação e Formação 725 –
Tecnologias de Diagnóstico e Terapêutica / Medicina Nuclear
Keywords
Drug development Molecular imaging Nuclear imaging PET/SPECT biomarkers Radiochemistry